• Download mobile app
02 Mar 2021, Edition - 2058, Tuesday

Trending Now

  • Gujarat: Delhi CM Arvind Kejriwal holds road show in Surat, 3 days after the Gujarat civic polls.
  • Covid-19 vaccination: Registration of beneficiaries on Co-WIN for 2nd phase to start from March 1
  • India’s cumulative COVID-19 vaccination coverage has crossed 1.34 crores, says Union Health Ministry
  • India allows Pakistan PM Imran Khan to use airspace while flying to Colombo
  • Mathura will break ego and arrogance of BJP: Priyanka Gandhi
  • Farmers will gherao Parliament if government doesn’t repeal three agriculture laws: Tikait

Businesswire

Eurofins Announces Acquisition of Assets of Gomti Life Sciences

by businesswireindia.com

Share
Business Wire India
Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life Sciences Private Limited through a Business Transfer Agreement. The assets include a fully equipped state-of-the-art manufacturing facility located in Bidadi Industrial Area, Bangalore, India, with cGMP pilot plant, intermediate area and ISO class 8 clean rooms and a total reactor capacity of about 45 KL. 

With this acquisition, Eurofins Advinus will be able to manufacture RSMs, intermediates, APIs and NCEs. The company can now support drug substance requirements from multi kilogram to MT scale for Toxicology studies, clinical trials and launch quantities.

Rajiv Malik, MD of Eurofins Advinus Limited commented: This acquisition could be a game changer for Eurofins Advinus as it enables the group to enter clinical development and commercial supply part of the Pharma R&D value chain through cGMP API supplies of NCEs. This addition is also a part of a larger foray of the Eurofins group into CDMO / CRAMS market.
Source: Businesswire
COIMBATORE WEATHER